Kyverna Therapeutics (KYTX) Earnings Date & Reports
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
KYTX is expected to report earnings to rise 18.82% to -100 cents per share on April 01
Q4'25
Est.
$-1.01
Q3'25
Beat
by $0.17
Q2'25
Beat
by $0.05
Q4'24
Beat
by $0.08
Q3'24
Beat
by $0.04
The last earnings report on November 13 showed earnings per share of -85 cents, beating the estimate of -101 cents. With 36.20K shares outstanding, the current market capitalization sits at 516.19M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. KYTX showed earnings on November 13, 2025. You can read more about the earnings report here.